138 related articles for article (PubMed ID: 18459759)
1. Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target.
Friesen RW; Mancini JA
J Med Chem; 2008 Jul; 51(14):4059-67. PubMed ID: 18459759
[No Abstract] [Full Text] [Related]
2. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
3. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
Korotkova M; Jakobsson PJ
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
[TBL] [Abstract][Full Text] [Related]
4. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production.
Ikeda-Matsuo Y; Ikegaya Y; Matsuki N; Uematsu S; Akira S; Sasaki Y
J Neurochem; 2005 Sep; 94(6):1546-58. PubMed ID: 16000148
[TBL] [Abstract][Full Text] [Related]
5. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2.
Sampey AV; Monrad S; Crofford LJ
Arthritis Res Ther; 2005; 7(3):114-7. PubMed ID: 15899061
[TBL] [Abstract][Full Text] [Related]
6. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Wang M; Song WL; Cheng Y; Fitzgerald GA
J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis.
Engblom D; Saha S; Engström L; Westman M; Audoly LP; Jakobsson PJ; Blomqvist A
Nat Neurosci; 2003 Nov; 6(11):1137-8. PubMed ID: 14566340
[TBL] [Abstract][Full Text] [Related]
8. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
9. Impaired vagus-mediated immunosuppression in microsomal prostaglandin E synthase-1 deficient mice.
Le Maître E; Revathikumar P; Idborg H; Raouf J; Korotkova M; Jakobsson PJ; Lampa J
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):155-62. PubMed ID: 26001880
[TBL] [Abstract][Full Text] [Related]
10. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
[TBL] [Abstract][Full Text] [Related]
11. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
Timmers L; Pasterkamp G; de Kleijn DP
Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
13. Discovery of depsides and depsidones from lichen as potent inhibitors of microsomal prostaglandin E2 synthase-1 using pharmacophore models.
Bauer J; Waltenberger B; Noha SM; Schuster D; Rollinger JM; Boustie J; Chollet M; Stuppner H; Werz O
ChemMedChem; 2012 Dec; 7(12):2077-81. PubMed ID: 23109349
[TBL] [Abstract][Full Text] [Related]
14. Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1.
Wu TY; Juteau H; Ducharme Y; Friesen RW; Guiral S; Dufresne L; Poirier H; Salem M; Riendeau D; Mancini J; Brideau C
Bioorg Med Chem Lett; 2010 Dec; 20(23):6978-82. PubMed ID: 20965723
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor ligands inhibit the lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 and diminish prostaglandin E2 production in murine peritoneal macrophages.
Ninomiya Y; Yasuda T; Kawamoto M; Yuge O; Okazaki Y
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):44-50. PubMed ID: 17049841
[TBL] [Abstract][Full Text] [Related]
16. Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.
Ikeda-Matsuo Y; Tanji H; Ota A; Hirayama Y; Uematsu S; Akira S; Sasaki Y
Br J Pharmacol; 2010 Jun; 160(4):847-59. PubMed ID: 20590584
[TBL] [Abstract][Full Text] [Related]
17. Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice.
Chen L; Yang G; Monslow J; Todd L; Cormode DP; Tang J; Grant GR; DeLong JH; Tang SY; Lawson JA; Pure E; Fitzgerald GA
Proc Natl Acad Sci U S A; 2014 May; 111(18):6828-33. PubMed ID: 24753592
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
Moon Y; Glasgow WC; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
[TBL] [Abstract][Full Text] [Related]
19. HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity.
Goedken ER; Gagnon AI; Overmeyer GT; Liu J; Petrillo RA; Burchat AF; Tomlinson MJ
J Biomol Screen; 2008 Aug; 13(7):619-25. PubMed ID: 18626113
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
Tang SY; Monslow J; R Grant G; Todd L; Pawelzik SC; Chen L; Lawson J; Puré E; FitzGerald GA
Circulation; 2016 Jul; 134(4):328-38. PubMed ID: 27440004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
